[
    [
        {
            "time": "",
            "original_text": "【太平洋医药丨智飞生物】更新报告：EC诊断审批完毕待制证，近期有望批准上市",
            "features": {
                "keywords": [
                    "智飞生物",
                    "EC诊断",
                    "审批",
                    "上市"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【太平洋医药丨智飞生物】更新报告：EC诊断审批完毕待制证，近期有望批准上市",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【天风医药】智飞生物：1季度受疫情影响业绩相对平稳，EC、微卡疫苗等有望开启发展新阶段",
            "features": {
                "keywords": [
                    "智飞生物",
                    "疫情",
                    "业绩",
                    "EC",
                    "微卡疫苗",
                    "发展新阶段"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral_positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【天风医药】智飞生物：1季度受疫情影响业绩相对平稳，EC、微卡疫苗等有望开启发展新阶段",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]